Literature DB >> 31296576

Blood transcriptome and clonal T-cell correlates of response and non-response to eltrombopag therapy in a cohort of patients with chronic immune thrombocytopenia.

Haiyu Zhang1, Bing M Zhang1, Xiangqian Guo1,2, Liwen Xu1, Xiaoqing You1, Robert B West1, James B Bussel3, James L Zehnder4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31296576      PMCID： PMC7049341          DOI： 10.3324/haematol.2019.226688

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.

Authors:  Francesco Rodeghiero; Roberto Stasi; Terry Gernsheimer; Marc Michel; Drew Provan; Donald M Arnold; James B Bussel; Douglas B Cines; Beng H Chong; Nichola Cooper; Bertrand Godeau; Klaus Lechner; Maria Gabriella Mazzucconi; Robert McMillan; Miguel A Sanz; Paul Imbach; Victor Blanchette; Thomas Kühne; Marco Ruggeri; James N George
Journal:  Blood       Date:  2008-11-12       Impact factor: 22.113

2.  Transforming growth factor-beta1 (TGF-beta1) induces thrombopoietin from bone marrow stromal cells, which stimulates the expression of TGF-beta receptor on megakaryocytes and, in turn, renders them susceptible to suppression by TGF-beta itself with high specificity.

Authors:  S Sakamaki; Y Hirayama; T Matsunaga; H Kuroda; T Kusakabe; T Akiyama; Y Konuma; K Sasaki; N Tsuji; T Okamoto; M Kobune; K Kogawa; J Kato; R Takimoto; R Koyama; Y Niitsu
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

3.  Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes.

Authors:  Jesse W Rowley; Andrew J Oler; Neal D Tolley; Benjamin N Hunter; Elizabeth N Low; David A Nix; Christian C Yost; Guy A Zimmerman; Andrew S Weyrich
Journal:  Blood       Date:  2011-05-19       Impact factor: 22.113

4.  T cell receptor VB repertoire diversity in patients with immune thrombocytopenia following splenectomy.

Authors:  P F Fogarty; M E Rick; W Zeng; A M Risitano; C E Dunbar; J B Bussel
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

5.  Transforming growth factor beta inhibits megakaryocyte growth and endomitosis.

Authors:  D J Kuter; D M Gminski; R D Rosenberg
Journal:  Blood       Date:  1992-02-01       Impact factor: 22.113

6.  Gender and duration of disease differentiate responses to rituximab-dexamethasone therapy in adults with immune thrombocytopenia.

Authors:  John Chapin; Christina S Lee; Haiyu Zhang; James L Zehnder; James B Bussel
Journal:  Am J Hematol       Date:  2016-06-20       Impact factor: 10.047

7.  Defective regulatory B-cell compartment in patients with immune thrombocytopenia.

Authors:  Xiaojuan Li; Hui Zhong; Weili Bao; Nayla Boulad; Jessie Evangelista; Muhammad Anis Haider; James Bussel; Karina Yazdanbakhsh
Journal:  Blood       Date:  2012-08-02       Impact factor: 22.113

8.  Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura.

Authors:  Roberto Stasi; Giovanni Del Poeta; Elisa Stipa; Maria Laura Evangelista; Margherita M Trawinska; Nichola Cooper; Sergio Amadori
Journal:  Blood       Date:  2007-06-04       Impact factor: 22.113

9.  3'-end sequencing for expression quantification (3SEQ) from archival tumor samples.

Authors:  Andrew H Beck; Ziming Weng; Daniela M Witten; Shirley Zhu; Joseph W Foley; Phil Lacroute; Cheryl L Smith; Robert Tibshirani; Matt van de Rijn; Arend Sidow; Robert B West
Journal:  PLoS One       Date:  2010-01-19       Impact factor: 3.240

10.  Time-Dependent Decay of mRNA and Ribosomal RNA during Platelet Aging and Its Correlation with Translation Activity.

Authors:  Catherine Angénieux; Blandine Maître; Anita Eckly; François Lanza; Christian Gachet; Henri de la Salle
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240
View more
  3 in total

Review 1.  Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment.

Authors:  Oriana Miltiadous; Ming Hou; James B Bussel
Journal:  Blood       Date:  2020-02-13       Impact factor: 22.113

2.  Elucidating the Mechanism of Action of the Attributed Immunomodulatory Role of Eltrombopag in Primary Immune Thrombocytopenia: An In Silico Approach.

Authors:  Maria L Lozano; Cristina Segú-Vergés; Mireia Coma; María T Álvarez-Roman; José R González-Porras; Laura Gutiérrez; David Valcárcel; Nora Butta
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

3.  Diagnosis of immune thrombocytopenia, including secondary forms, and selection of second-line treatment.

Authors:  James B Bussel; Christine A Garcia
Journal:  Haematologica       Date:  2022-09-01       Impact factor: 11.047
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.